Cruise stocks surge after Moderna reports upbeat news its COVID-19 vaccine candidate

/ / News

Shares of cruise operators charged higher Monday, after Moderna Inc.’s said its COVID-19 vaccine candidate demonstrated better-than 94% efficacy in a Phase 3 trial. Shares of Carnival Corp shot up 6.9% in premarket trading, after being up about 4.7% prior to Moderna’s news. Royal Caribbean Group’s stock ran up 6.5% ahead of the open and Norwegian Cruise Line Holdings Ltd. shares surged 9.0%. Meanwhile, futures for the S&P 500 rallied 1.2%. Cruise operators have been among the hardest hit by the COVID-19 pandemic, as they have struggled to resume operations amid government restrictions in the U.S. and abroad.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.